Vala Sciences, founded in 2004, is a pioneering biotechnology company headquartered in the United States. The company distinguishes itself with a clear mission encapsulated in its slogan: "Vala enables precision drug discovery with fully automated analysis of hiPSC single-cell kinetics." This highlights their dedication to transforming drug discovery through innovative technology.
Focusing on critical areas like cardiac biology and neuroscience, Vala Sciences offers cutting-edge kinetic data analysis to pharmaceutical developers and researchers. By utilizing proprietary platforms such as the Kinetic Image Cytometer (KIC®) and Structured Illumination Microscopy (SIM), alongside their CyteSeer® software, they provide comprehensive insights into cellular responses, enhancing the understanding of drug efficacy and toxicity with high accuracy.
Despite a strong foothold in the biotechnology sector, Vala Sciences has not announced recent investments, suggesting an opportunity for venture capitalists to partner in their journey towards reducing clinical failures and improving drug discovery outcomes.